Literature DB >> 17011495

An intrinsic cell cycle checkpoint pathway mediated by MEK and ERK in Drosophila.

Vladic Mogila1, Fan Xia, Willis X Li.   

Abstract

Cell cycle checkpoints are surveillance mechanisms that safeguard genome integrity. While the extrinsic pathways that halt the cell cycle in response to DNA damages have been well documented, the intrinsic pathways that ensure orderly progression of cell cycle events are not well understood. We demonstrate that Drosophila MEK and ERK constitute an essential intrinsic checkpoint pathway that restrains cell cycle progression in the absence of DNA damage and also responds to ionizing radiation to arrest the cell cycle. Embryos lacking MEK exhibit faster and extra division cycles and fail to undergo timely midblastula transition (MBT) or arrest following ionizing radiation. Conversely, constitutively activated MEK causes cell cycle arrest. Further, MEK activation in the early embryo is cell cycle-dependent and Raf independent and increases in response to ionizing radiation or in the absence of Chk1. Thus, MEK/ERK activation is required for multiple checkpoints and is essential for orderly cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011495      PMCID: PMC3095892          DOI: 10.1016/j.devcel.2006.08.010

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  26 in total

Review 1.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity.

Authors:  Saeko Takada; Anju Kelkar; William E Theurkauf
Journal:  Cell       Date:  2003-04-04       Impact factor: 41.582

3.  Both cyclin B levels and DNA-replication checkpoint control the early embryonic mitoses in Drosophila.

Authors:  Jun-Yuan Ji; Jayne M Squirrell; Gerold Schubiger
Journal:  Development       Date:  2003-12-17       Impact factor: 6.868

4.  MEK inhibition and phosphorylation of serine 4 on B23 are two coincident events in mitosis.

Authors:  Cynthia Hayne; Xiaoqin Xiang; Zhijun Luo
Journal:  Biochem Biophys Res Commun       Date:  2004-08-27       Impact factor: 3.575

5.  Phosphorylation of Cdc20 is required for its inhibition by the spindle checkpoint.

Authors:  Eunah Chung; Rey-Huei Chen
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

6.  Mos mediates the mitotic activation of p42 MAPK in Xenopus egg extracts.

Authors:  Jianbo Yue; James E Ferrell
Journal:  Curr Biol       Date:  2004-09-07       Impact factor: 10.834

7.  MKP-3 has essential roles as a negative regulator of the Ras/mitogen-activated protein kinase pathway during Drosophila development.

Authors:  Myungjin Kim; Guang-Ho Cha; Sunhong Kim; Jun Hee Lee; Jeehye Park; Hyongjong Koh; Kang-Yell Choi; Jongkyeong Chung
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

9.  BRAF and RAS mutations in human lung cancer and melanoma.

Authors:  Marcia S Brose; Patricia Volpe; Michael Feldman; Madhu Kumar; Irum Rishi; Renee Gerrero; Eugene Einhorn; Meenhard Herlyn; John Minna; Andrew Nicholson; Jack A Roth; Steven M Albelda; Helen Davies; Charles Cox; Graham Brignell; Philip Stephens; P Andrew Futreal; Richard Wooster; Michael R Stratton; Barbara L Weber
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

10.  l(1)pole hole is required maternally for pattern formation in the terminal regions of the embryo.

Authors:  L Ambrosio; A P Mahowald; N Perrimon
Journal:  Development       Date:  1989-05       Impact factor: 6.868

View more
  12 in total

1.  Enhancing CHK1 inhibitor lethality in glioblastoma.

Authors:  Yong Tang; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2012-04-01       Impact factor: 4.742

2.  ARF triggers cell G1 arrest by a P53 independent ERK pathway.

Authors:  Hansong Du; Weiqi Yao; Min Fang; Dongcheng Wu
Journal:  Mol Cell Biochem       Date:  2011-06-10       Impact factor: 3.396

3.  Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2.

Authors:  Xin-Yan Pei; Yun Dai; Leena E Youssefian; Shuang Chen; Wesley W Bodie; Yukie Takabatake; Jessica Felthousen; Jorge A Almenara; Lora B Kramer; Paul Dent; Steven Grant
Journal:  Blood       Date:  2011-09-12       Impact factor: 22.113

Review 4.  Four-dimensional dynamics of MAPK information processing systems.

Authors:  Boris N Kholodenko; Marc R Birtwistle
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

5.  Unphosphorylated STAT and heterochromatin protect genome stability.

Authors:  Shian-Jang Yan; Su Jun Lim; Song Shi; Pranabananda Dutta; Willis X Li
Journal:  FASEB J       Date:  2010-09-16       Impact factor: 5.191

Review 6.  CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Authors:  Paul Dent; Yong Tang; Adly Yacoub; Yun Dai; Paul B Fisher; Steven Grant
Journal:  Mol Interv       Date:  2011-04

7.  Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Authors:  Laura Riolobos; Noelia Valle; Eva Hernando; Beatriz Maroto; Michael Kann; José M Almendral
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

8.  Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.

Authors:  Yun Dai; Shuang Chen; Xin-Yan Pei; Jorge A Almenara; Lora B Kramer; Charis A Venditti; Paul Dent; Steven Grant
Journal:  Blood       Date:  2008-07-09       Impact factor: 22.113

9.  The candidate MAP kinase phosphorylation substrate DPL-1 (DP) promotes expression of the MAP kinase phosphatase LIP-1 in C. elegans germ cells.

Authors:  Baiqing Lin; Valerie Reinke
Journal:  Dev Biol       Date:  2008-01-08       Impact factor: 3.582

Review 10.  Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

Authors:  F Wei; J Yan; D Tang
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.